Browse studies

Find your next paid study

27,288 recruiting studies available now

Biomarker-Guided Antidepressant Selection for Treatment-Resistant Depression

Depression is one of the leading causes of disability worldwide. Common treatments like antidepressant medications and talk therapy work well for some people, …

Depression - Major Depressive DisorderTreatment-resistant Depression (TRD)rTMS+2 more

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Weill Medical College of Cornell UniversityNCT07680140

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

The objective of this study is to build a prospective cohort in patients with locally advanced or metastatic NSCLC with common EGFR mutations. In NPM-002, ther…

Non Small Cell Lung Cancer

Estimated

~$10 – $1,125

Actual pay is set by the research site.

N-Power MedicineNCT07028489

Cardiovascular Biorepository

Use biospecimens procured from patients and organ donors to improve understanding of molecular, cellular, and tissue-level processes produced by cardiovascular…

Cardiovascular Diseases

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Kenneth S. CampbellNCT00753974

Early Detection of Respiratory Impairments in ALS: A Novel Diagnostic Approach

The goal of this observational study is to develop new ways to detect early changes associated with amyotrophic lateral sclerosis (ALS), also known as Lou Gehr…

Amyotrophic Lateral Sclerosis (ALS)

Estimated

~$10 – $750

Actual pay is set by the research site.

Thomas Jefferson UniversityNCT07844590

Phase 2

A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Monotherapy Study of the Efficacy, Safety, and Tolerability of SPT-300 in Adults With Major Depressive Disorder (MDD), With or Without Anxious Distress

This is a randomized, parallel-group, double-blind, placebo-controlled, monotherapy study to evaluate the efficacy, safety, and tolerability of SPT-300 (GlyphA…

Major Depressive Disorder (MDD)Major Depressive Disorder With Anxious Distress

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Seaport TherapeuticsNCT07065240

Observational

Cost Effective Air Filtration Intervention and Particulate Matter Monitoring in Low-Income Housing to Reduce Asthma Morbidity

This project will investigate the effectiveness of HEPA air cleaners in reducing indoor air pollution and improving asthma morbidity in children living in East…

Asthma AttackLung FunctionAirway Inflammation

Estimated

~$10 – $750

Actual pay is set by the research site.

Columbia UniversityNCT07116460

A Prospective, Non-interventional (NIS), Long-term, Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

The goal of this study is to further characterise the potential long-term safety risks of lonapegsomatropin in patients treated with lonapegsomatropin under re…

Growth Hormone Deficiency

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Ascendis Pharma Endocrinology Division A/SNCT05775523

Observational

Feasibility of Using a Meditation App in Adults With Anxiety Disorder

The goal of this clinical trial is to learn if the FlowMD mobile app is feasible to be used to manage mild anxiety in adults. It will also learn if the app is …

Anxiety

Estimated

~$10 – $750

Actual pay is set by the research site.

National University of Natural MedicineNCT07672925

Phase 3

A Randomized, Double Blind, Multicenter Phase 3 Trial of BMS-986489 (Atigotatug+Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide vs Atezolizumab in Combination With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

The Purpose of the Study is to Compare the Efficacy and Safety of BMS-986489 (Anti-fucosyl-GM1+ Nivolumab Fixed Dose Combination) in Combination with Carboplat…

Extensive-Stage Small Cell Lung Cancer

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Bristol-Myers SquibbNCT06646276

Phase 2

Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

The objective of this study is to adapt the Patient Priorities Care (PPC) framework to breast cancer survivorship via a user-centered approach, through an iter…

Breast Cancer Survivorship

Estimated

~$75 – $2,000

Actual pay is set by the research site.

The University of Texas Health Science Center, HoustonNCT06478589

Phase 2

Subcutaneous Tranexamic Acid in Nasal Mohs Local Flap Reconstruction: Perioperative Bleeding, Edema, and Ecchymosis

This study will be a prospective randomized control trial to evaluate the effects of subcutaneously administered TXA among patients undergoing nasal Mohs recon…

Postoperative BleedingSkin Cancer Face

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Vanderbilt University Medical CenterNCT06057675

Observational

Hybrid Type 1 Effectiveness-Implementation Trial of a Proactive Smoking Cessation Electronic Visit for Scalable Delivery Via Primary Care

The purpose of this research study is to evaluate an electronic visit (e-visit) for smoking cessation. Participants will be randomly assigned to receive either…

Smoking Cessation

Estimated

~$10 – $750

Actual pay is set by the research site.

Medical University of South CarolinaNCT05493254